BaseCure Therapeutics is a Delaware area startup that is working on siRNAs for cardiometabolic diseases like hypertension and obesity

Acting CEO Jing Yang says the company's obesity approach will try to avoid the muscle wasting that comes with GLPs by focusing on the fat cells. They could be in the clinic sometime early next year.